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Abstract
Background: The leishmaniases are a group of vector-borne parasitic diseases that represent a major international public
health problem; they belong to the most neglected tropical diseases and have one of the highest rates of morbidity and
mortality. The clinical outcome of infection with Leishmania parasites depends on a variety of factors such as parasite
species, vector-derived products, genetics, behaviour, and nutrition. The age of the infected individuals also appears to be
critical, as a significant proportion of clinical cases occur in children; this age-related higher prevalence of disease is most
remarkable in visceral leishmaniasis. The mechanisms resulting in this higher incidence of clinical disease in children are
poorly understood. We have recently revealed that sustained arginase activity promotes uncontrolled parasite growth and
pathology in vivo. Here, we tested the hypothesis that arginase-mediated L-arginine metabolism differs with age.
Methodology: The age distribution of patients with visceral or cutaneous leishmaniasis was determined in cohorts of
patients in our clinics in endemic areas in Ethiopia. To exclude factors that are difficult to control in patients, we assessed
the impact of ageing on the manifestations of experimental leishmaniasis. We determined parasite burden, T cell responses,
and macrophage effector functions in young and aged mice during the course of infection.
Results: Our results show that younger mice develop exacerbated lesion pathology and higher parasite burdens than aged
mice. This aggravated disease development in younger individuals does not correlate with a change in T helper cytokine
profile. To address the underlying mechanisms responsible for the more severe infections in younger mice, we investigated
macrophage effector functions. Our results show that macrophages from younger mice do not have an impaired capacity to
kill parasites; however, they express significantly higher levels of arginase 1 than aged mice and promote parasite growth
more efficiently. Thus, our results demonstrate that ageing differentially impacts on L-arginine metabolism and subsequent
effector functions of physiologically distinct macrophage subsets.
Conclusions: Here, we show that arginase-mediated L-arginine metabolism is modulated with age and affects the capacity
of macrophages to express arginase; the increased capacity to upregulate this enzyme in younger individuals results in a
more permissive environment for parasite growth, increased disease severity and pathology. These results suggest that the
difference in arginase-mediated L-arginine catabolism is likely to be an important factor contributing to the increased
incidence of clinical cases in children. Thus, targeting L-arginine metabolism might be a promising therapeutic strategy
against leishmaniasis, especially in children and young adults.
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Introduction
Infections with protozoan parasites inflict an immense toll on
the developing world; they are major causes of morbidity and
mortality and impede economic development. Leishmaniases are
vector-borne diseases, the parasites being transmitted by bites of
blood feeding female sandflies and causing different disease
manifestations in humans, ranging from the relatively benign
self-healing cutaneous form through the disseminated and diffuse
cutaneous, to the most severe visceral leishmaniasis. Leishmaniases
belong to the most neglected diseases, yet they occur in five
continents and are endemic in almost all tropical and subtropical
areas [1]. The rising incidence of leishmaniasis around the world is
an increasing concern for many countries.
A multitude of factors, including parasite and vector species,
host immune responses, genetic and environmental factors
influence the outcome of infection. The age of the infected
individual also appears to be crucial, as a high proportion of the
patients are children. This age-related higher prevalence of disease
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The mechanisms resulting in this higher incidence of clinical cases
in children however are poorly understood.
Leishmania are obligate intracellular parasites they survive and
replicate predominantly in macrophages. Experimental infections
of inbred strains of mice with Leishmania (L.) major have established
the current paradigm of T helper (Th) subset involvement in
infectious diseases. Control of infection and healing has been
associated with a polarized Th1 response whereas non-healing is
attributed to a dominant Th2 response [11]. However, the
regulation of immune responses against Leishmania parasites is
complex and Th2 dominance does not fully explain non-healing or
reactivated forms of disease [12,13].
Macrophages, the main effector cells in leishmaniasis, can be
instructed to kill or to promote the growth of intracellular
Leishmania parasites, depending on the balance of two inducible
enzymes, nitric oxide synthase 2 (NOS2) and arginase. These two
enzymes use a common substrate, L-arginine, and are competi-
tively regulated by type1 and type 2 cytokines [14]. The fate of the
intracellular parasite depends on the type of signal the macro-
phages receive: the type 1 cytokine interferon-c (IFN-c) induces
classical activation of macrophages and expression of NOS2 that
oxidizes L-arginine into nitric oxide (NO), a metabolite responsible
for parasite killing [15]; the key type 2 cytokine IL-4 results in
alternative activation of macrophages and the induction of
arginase [16,17]. Arginase initiates one of the classic pathways of
arginine degradation and it regulates NO synthesis [18]. Two
distinct arginase isoforms, encoded by different genes and differing
in their cellular localization, have been identified in mammals:
type 1 arginase is cytosolic and type 2 arginase is mitochondrial
[19]. Arginase hydrolyzes L-arginine to urea and ornithine; the
latter being the main intracellular source for synthesis of
polyamines necessary for parasite growth. Indeed, we recently
showed that sustained arginase activity promotes uncontrolled
parasite growth and pathology in vivo [20].
In the current study we tested the hypothesis that arginase-
mediated L-arginine metabolism is altered with age and thereby
modulates the capacity of macrophages to control parasite growth.
Materials and Methods
Mice
3–4 and 6–8 week old female BALB/c mice (Charles River,
UK) were kept in individually vented cages for up to 18 months.
The animal colonies, screened regularly for mouse pathogens,
consistently tested negative. Animal experiments were performed
in accordance with Home Office and institutional guidelines.
Patients
Data from 91 patients diagnosed with cutaneous leishmaniasis
(CL) at the University of Addis Ababa in the time period from July
2005–April 2007 were used for determination of age distribution
of CL. Diagnosis was confirmed by smear and/or NNN culture
and later confirmed to be due to L. aethiopica by biochemical typing
of randomly selected strains. Typing of selected strains was done
by a multi-locus enzyme electrophoresis (MLEE) technique at the
Istituto Superiore di Sanita in Rome, Italy.
Data from 37 patients diagnosed from 1997–2000 with visceral
leishmaniasis (VL) from an endemic region in Ethiopia were used
to determine the age distribution of VL. All VL cases were due to
L. donovani (determined by MLEE) and were diagnosed as
described [21]. The presence of parasites in lymph node or
splenic aspirates was assessed by direct smear or culture [21].
Experimental infection with L. major parasites
For infections, 2610
6 L. major LV39 (MRHO/SU/59/P-strain)
promastigotes were injected s.c. into the footpad and lesions were
monitored as described [22].
Determination of parasite load
The number of living L. major parasites in infected tissues was
determined using the parasite limiting dilution assay [22].
Determination of arginase activity
Arginase activity was measured in macrophage lysates as
previously described [14,20]. One unit of enzyme activity was
defined as the amount of enzyme that catalyzes the formation of
1 mmol of urea per min.
Arginase activity at the site of lesions was determined ex vivo
using 1–10 ml of footpad homogenate, and the method described
above.
Amastigotes were purified from the lesions as described in [23]
and arginase activity was determined as described above.
Western Blot Analysis
Arginase 1 protein expression was determined by western blot
as described [20], using anti-arginase 1, a rabbit polyclonal
antibody raised against rat arginase 1, which cross-reacts with
mouse arginase 1 but not arginase 2 [24].
Cytokine measurements
Draining lymph nodes from individual mice (5610
6 cells/ml)
were restimulated with 1610
6/ml L. major promastigotes. Forty-
eight hours later, culture supernatants were harvested and
cytokines determined by ELISA according to the supplier’s
protocol (Pharmingen). Detection limits are 20 pg/ml for IL-4,
20 pg/ml for IL-10 and 1 U/ml for IFN-gamma.
The frequency of CD4
+ T cells expressing IL-4, IL-10 or IFN-c
was determined by flowcytometry as described [25]. Detection of
intracellular cytokines was determined using an EPICS XL
instrument (Beckman Coulter). Data were analyzed using Beck-
man Coulter Expo 32 software.
Proliferation assay
The proliferative capacity of CD4
+ T cells was determined by
flowcytometry, measuring BrdU incorporation as described [26].
Author Summary
It is well documented that ageing alters many aspects of
immune responses; however, a causal relation between
impaired immune functions in ageing individuals and the
response to infection has not been established. Experi-
mental leishmaniasis is an excellent model to analyse
protective and pathological immune responses. Leishman-
ia parasites are obligate intracellular pathogens and invade
mainly macrophages, which have dual function: they can
kill the parasites or promote their growth. We have
recently shown that arginase, an enzyme induced in
infected macrophages, is a key factor for parasite survival.
Here, we show that ageing reduces the expression levels
of arginase in macrophages, resulting in more efficient
control of parasite growth. Our results suggest that age-
related differences in the metabolism of arginase in
macrophages might contribute to the higher susceptibility
of children to leishmaniasis.
Arginase and Leishmaniasis
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Bone marrow obtained by flushing the femurs of naı ¨ve mice was
cultured during 8 days in hydrophobic Teflon bags as described
[14].
Macrophage activation markers
Macrophages were stimulated with 100 U/ml IFN-g (Pepro-
tech) and 500 U/ml TNF-a (Peprotech) or with 20 U/ml IL-4
(Peprotech) for 48 hr. BMMW (5610
5) were incubated with FcR
blocking reagent (Pharmingen) for 5 min and anti-CD206
(Serotec), anti-CD40, anti-CD80 or anti-CD86 mAbs
(eBioscience) were added for 20 min at 4uC. The expression of
CD206, CD40, CD80 and CD86 was determined using an EPICS
XL instrument (Beckman Coulter).
Nitrite determination
NO2
2 accumulation was used as an indicator of NO production
and measured using Griess reagent [22].
Determination of L. major parasite growth in
macrophages
Mature macrophages (5610
5/ml) were plated and stimulated
with either 100 U/ml IFN-c (Peprotech) and 500 U/ml TNF-a
(Peprotech) or indicated concentrations of IL-4 or IL-13
(Peprotech) and infected with 25610
5/ml L. major parasites. After
four days the macrophages were washed, lysed and the number of
viable parasites was determined as described [22].
Statistical analyses
Statistical differences were determined using a two-tailed Mann-
Whitney test. Differences were considered statistically significant at
P,0.05.
Results
Effect of age on disease development
To assess the impact of ageing on the development of
experimental leishmaniasis, genetically susceptible young (6–8
week) and older (12 months) BALB/c mice were infected s.c.
with L. major parasites and lesion development and parasite load
were determined. The onset of lesion development was similar
in both groups of mice. After three weeks of infection, the young
BALB/c mice started to develop ulcers and 4 weeks later, the
experiment had to be terminated owing to severity of the
lesions. In contrast, older BALB/c mice had clearly reduced
pathology; they did not develop ulcers and their lesions
stabilized (Figure 1a). Consistent with the exacerbated pathol-
ogy and increased lesion size, the parasite load at the site of the
lesion was significantly higher in the young than in old BALB/c
mice (Figure 1b). Similar results were obtained with mice aged
8, 12 and 18 months (data not illustrated). These results show
that disease pathology is clearly exacerbated in young BALB/c
mice.
Data obtained on leishmaniasis in our clinics in endemic
regions of Ethiopia show that 67% of cases of cutaneous
leishmaniasis occur in people younger than 26, and even more
striking, 85% of cases of visceral leishmaniasis occur in children
under 16 years (Figure 2). Thus in the human, the majority of
the clinical cases appears to occur in younger individuals.
Whereas many factors are likely to contribute to this higher
prevalence of clinical cases in younger individuals, these data
supports our finding that age is a major factor in the control of
disease.
Increased disease severity is not associated with a
significant alteration of the Th phenotype
To assess whether the increased disease severity (Figures 1a and
b) observed in young BALB/c mice correlated with modulation of
the T helper phenotype, we determined antigen-specific cytokine
production by lymph node cells. Interestingly in all experiments
performed there was a consistent increase in the levels of antigen-
specific IFN-c, IL-4 and IL-10 in the aged mice, however, these
differences were not statistically significant (P.0.05) (Figure 3 and
Table 1). In agreement with these results, the frequencies of CD4
+
T cells expressing IFN-c, IL-4 or IL-10 were not significantly
different between young and aged mice (Table 2). In addition, the
capacity of CD4
+ T cells to proliferate in response to L. major
parasites was similar (Table 2).
These results indicate that increased disease severity in young
BALB/c mice is unlikely to be due to alterations in the key Th
cytokine profile.
Higher arginase activity at the site of pathology
correlates with disease exacerbation
We have recently shown that in L. major infected healer strains of
mice (CBA, C57BL/6), arginase activity is low, only detectable
during active disease. In contrast, increasing arginase activity was
detected at the local site of lesion, and clearly correlated with
uncontrolled parasite replication and lesion size in nonhealing
BALB/c mice [20]. To assess whether the exacerbation of disease
in young mice was also associated with higher arginase expression
at the site of infection, we determined the activity of this enzyme.
The data presented in Figure 4a do indeed show significantly
higher arginase activity in the lesions of young BALB/c mice than
in those of their older counterparts. We also determined arginase 1
protein expression by Western blot and found arginase to be
higher in the lesions of young mice (Figure 4b).
Hormones such as estrogens can influence resistance to
infections [27,28,29,30,31]; since estrogens are significantly higher
in mice of reproductive age, in the next experiment we use pre-
pubertal mice aged 3–4 weeks and determined whether they
displayed an altered resistance to L. major infection. As shown in
Figure 4c, the lesion size was slightly higher in 3–4 weeks old mice
as compared to those of young adult mice (10 week old).
Importantly lesion sizes from 3–4 and 10 week old mice were
significantly higher then those of aged mice (40 week old).
Accordingly, both parasite loads and arginase activities at the site
of infection were significantly increased in both pre-pubertal and
adult mice as compared to aged mice.
The increased arginase activity and arginase protein expression
in the lesions of young L. major infected BALB/c mice support our
hypothesis that arginase mediated L-arginine metabolism alters
with age. These results further confirm our previous conclusion
that the level of arginase activity correlates with disease severity
[20].
We and others have shown that Leishmania parasites express
their own arginase [20,32,33]. Therefore, to measure the
contribution of parasite arginase to the total levels of arginase
activity measured in the lesions of BALB/c mice, we measured
arginase in the whole lesions, as well as in amastigotes purified
from lesions. As shown in Figure 4d, we could detect low levels of
arginase activity in the purified amastigotes, however it was 40.5-
fold lower as compared to that detected in the parasitised lesions.
No arginase 1 protein was detectable by Western blot in the
purified amastigotes (data not shown). These results show that
arginase activity from amastigotes only contributes minimally to
arginase activity measured in the lesions.
Arginase and Leishmaniasis
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Since macrophages are the ultimate effector cells, and arginase
activity is increased in lesions of young mice, we reasoned that
macrophages derived from old and young mice must differ in the
efficiency of their effector functions. To test this hypothesis, we first
examined the expression of activation markers on classically
activated macrophages (CAMW) No differences were detected in
the expression of CD86, CD40, CD80 and CD206 between
CAMW from young and older mice (Figure 5a). We also assessed
the capacity of CAMW from young and old mice to upregulate
NOS2 and produce NO. MW from both groups produced similar
levels of NO in response to IFN-c/TNF-a in the absence or
presence of parasites (Figure 5b). Furthermore, we determined NO
production by CAMW derived from pre-pubertal, adult and aged
mice. As shown in Table 3, NO production was similar in all age
groups.
We conclude that ageing does not affect the capacity of CAMW
to induce NOS2 or to generate NO and did not alter expression
levels of activation markers in CAMW.
Alternatively activated macrophages derived from young
mice express higher levels of arginase
We next examined the capacity of alternatively activated (AA)
MW from young and old mice to exert their effector functions.
AAMW were obtained by differentiating mature bone marrow MW
with IL-4 or IL-13 alone, as IL-10, which synergizes with IL-4 and
strongly enhances the expression levels of arginase, acts on a
different receptor [17]. We found no differences in the expression
of CD206, CD40, CD80 and CD86 between AAMW derived from
young and older mice (Figure 6a). We then assessed the capacity of
macrophages from young and older mice to induce arginase in
response to IL-4 or IL-13. As shown in Figure 6b, upregulation of
arginase was observed in both age groups of AAMW, and infection
with L. major parasites enhanced the arginase levels even further.
Importantly, AAMW derived from young mice displayed signifi-
cantly higher arginase activity in response to IL-4 or IL-13. We
also examined the capacity of AAMW derived from pre-pubertal
BALB/c mice (3–4 weeks) to express arginase; as shown in Table 4,
similarly to adult mice, they express significantly more arginase
then aged mice (40 weeks). These results show that ageing alters
the capacity of AAMW to express arginase.
Higher arginase activity correlates with increased
parasite replication in macrophages derived from young
mice
The polyamines resulting from the hydrolysis of L-arginine by
arginase are essential for parasite growth [20,34]. Here we
hypothesize that lower arginase activity in AAMW from older mice
Figure 1. Severity of experimental leishmaniasis is increased in young BALB/c mice. Groups of young (6–8 weeks) and older (12 months)
BALB/c mice were infected with 2610
6 L. major promastigotes in one hind footpad. (a) The lesion development was monitored by measuring the
increase in footpad thickness at regular intervals; the error bars represent standard error of the mean; (b) the parasite load was determined by limiting
dilution assay 4 weeks post infection; the horizontal bar represents the average value. Data show the results of one representative experiment out of
six independent experiments.
doi:10.1371/journal.pntd.0000235.g001
Figure 2. Age distribution of visceral and cutaneous leishman-
iasis. The age distribution of patients suffering from visceral (n=37,
circle) or cutaneous (n=91, triangle) leishmaniasis was determined in
endemic areas of Ethiopia.
doi:10.1371/journal.pntd.0000235.g002
Arginase and Leishmaniasis
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replication.
To determine whether AAMW from young and old mice
support L. major replication differently, we examined the number
of viable parasites by limiting dilution assay. There is a clearly
higher parasite load in AAMW derived from young mice
compared to those in older mice (Figure 7), indicating that
AAMW from young mice promote parasite growth more
effectively then AAMW from older mice. CAMW from both
groups, however, are equally efficient in parasite killing
(Figure 7), suggesting transport of L-arginine is sufficient in both
age groups.
The results show that AAMW from young mice provide a more
permissive environment for parasite growth, directly linking the
higher arginase activity (Figures 1b, 4 and 6) to increased parasite
replication (Figure 7).
Discussion
Our results show that younger BALB/c mice develop clearly
exacerbated disease as compared to older mice, as demonstrated
by more pronounced lesions, pathology and higher parasite
burdens at the site of parasite inoculation. This aggravation of
disease correlates with a higher arginase activity expressed at the
site of infection. This is due to altered macrophage effector
functions, as AAMW derived from younger mice have an increased
capacity to express arginase. To our knowledge, this is the first
report showing an age-related modulation of arginase expression.
Figure 3. Exacerbation of disease in young BALB/c mice is not associated to a switch in Th phenotype. Groups of young (6–8 weeks) and
older (12 months) BALB/c mice were infected with 2610
6 L. major promastigotes in one hind footpad. Four weeks post infection, the popiteal lymph
nodes were harvested and restimulated with L. major parasites. The supernatant were harvested and tested for their content of cytokines by ELISA.
The error bars represent standard error of the mean and data show the results of one representative experiment out of three independent
experiments.
doi:10.1371/journal.pntd.0000235.g003
Table 1. Cytokine production.
Exp. 1 IFN-c (U/ml) IL-4 (pg/ml) IL-10 (pg/ml)
Young 92.8639.4 703.56261.5 1181.86499.0
Aged 202.8666.8 1066.06232.7 20926733
Exp. 2
Young 33.768.8 1234.76212.4 1650.86202.3
Aged 86.9630.9 1579.76261.1 22046594.4
Exp. 3
Young 28.067.4 899.56144.0 1425.36360.7
Aged 50.3610.4 1033.5676.1 1723.36276.7
Groups of young (6–8 weeks) and older (12 months) BALB/c mice were infected
with 2610
6 L. major promastigotes in one hind footpad. Four weeks post
infection, the popliteal lymph nodes were harvested and restimulated with L.
major parasites. The supernatant were harvested and tested for their content of
cytokines by ELISA. The data represent the cytokine concentration6standard
error of the mean and data show the results of three independent experiments
are represented.
doi:10.1371/journal.pntd.0000235.t001
Table 2. Proliferation and frequency of cytokine-producing
CD4
+ T cells.
Proliferation Cytokine expression
% CD4
+BrdU
+ % CD4
+IFN-c
+ % CD4
+IL-4
+ % CD4
+IL-10
+
Young 28.763.7 16.462.6 16.263.8 11.062.5
Aged 28.068.5 20.463.3 15.063.4 10.061.1
Groups of young (6–8 weeks) and older (12 months) BALB/c mice were infected
with 2610
6 L. major promastigotes in one hind footpad. Four weeks post
infection, the popiteal lymph nodes were harvested and restimulated with L.
major parasites. The frequency of cytokine-expressing CD4
+ T cells was
determined by intracellular cytokine staining and the frequency of proliferating
CD4
+ T cells was determined by BrdU incorporation.
Data show the results of one representative experiment out of three
independent experiments.
doi:10.1371/journal.pntd.0000235.t002
Arginase and Leishmaniasis
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of lesion in L. major infected younger BALB/c mice. We have
recently shown that sustained arginase activity promotes uncon-
trolled parasite growth in BALB/c mice and is pivotal for parasite
growth [20]. Thus, increased arginase activity in macrophages
from young mice results in increased L-arginine catabolism and
consequently increased levels of polyamines, providing a more
permissive environment for parasite replication.
The reduced parasite growth in macrophages from elderly mice
could be due to enhanced parasite killing or reduced parasite
growth or a combination of both. The results presented in Fig. 5b
show that the potential of bone marrow derived classically
activated macrophages to generate nitric oxide is comparable in
cells derived from young, adult and elderly mice.
In contrast, the potential to induce arginase activity declined
with age and the presence of L. major parasites further enhanced
arginase activity (Fig. 6b). Both arginase and iNOS compete for
utilizing L-arginine, however, this does not necessarily indicate
that the increased susceptibility is due insufficient parasite killing.
Improved control of parasite growth in the elderly is not
necessarily due to a shift of the L-arginine metabolism towards
the iNOS pathway and enhanced NO production. The expression
of both of the L-arginine metabolizing enzymes in macrophages is
induced by type 1 and type 2 cytokines, respectively and activation
of macrophages results in increased expression of cationic amino
acid transporters and increased transport of L-arginine into the
macrophages; both enzyme levels and L-arginine transport
determine the catabolic rate. Thus, the net-effect of unaltered
generation of NO (=constant rate of killing) and reduced
induction of arginase activity (=reduced nutrients, reduced
growth) with age is likely to account for the improved disease
control. Indeed, we previously showed that arginase directly
regulates parasite growth without affecting NO synthesis [20]. In
this context, it is important to note that macrophages synthesize
Figure 4. Higher arginase activity at the site of pathology correlates with exacerbation of disease. Groups of young (6–8 weeks) and
older (12 months) BALB/c mice were infected with 2610
6 L. major promastigotes in one hind footpad. Four weeks post infection, the infected
footpads were harvested and the level of arginase activity was determined by enzymatic assay (a) or western blot (b). (c) Groups of pre-pubertal mice
(3–4 weeks), adult (10 weeks) or older (40 weeks) BALB/c mice were infected with 2610
6 L. major promastigotes in one hind footpad and the lesion
development was monitored by measuring the increase in footpad thickness at regular intervals; the error bars represent standard error of the mean
(left panel); 4 weeks post infection, the infected footpads were harvested and the parasite load (upper right panel) and arginase activity (lower right
panel) were measured. (d) BALB/c mice were infected with 2610
6 L. major promastigotes in one hind footpad. Four weeks post infection, the infected
footpads were harvested and arginase activity was determined both in the footpads and in the amastigotes purified from the footpads. The
horizontal bar represents the average value and data show the results of one representative experiment out of three independent experiments.
doi:10.1371/journal.pntd.0000235.g004
Arginase and Leishmaniasis
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proline could also be used by the parasites. In agreement with our
findings, arginase 1 has been shown to be limiting for polyamine
synthesis without affecting NO levels in activated macrophages
[35,36].
We have previously shown that the levels of arginase 1
expressed by L. major parasites influence their virulence [32] and
parasite arginase can catabolize radioactive labelled L-arginine
[32]. Thus, parasite arginase activity is likely to influence the early
immune response. Importantly, the levels of arginase expressed by
intracellular L. major amastigotes are negligible as compared to
macrophage arginase (Figure 4d) [32]. In agreement with these
findings, a recent publication showed that arginase activity
expressed by L. mexicana amastigotes is only a minute fraction
compared to the macrophages arginase activity (0.418 in
macrophages, 0.0235 by parasites [37]).
In conclusion, these in vitro results indicate that macrophages
from aged mice provide a less favourable environment for parasite
growth than those from younger mice due to reduced nutrient
availability.
Ageing is generally associated with a decline of immune
responses [38] and some responses can be improved by targeting
L-arginine metabolism [39]. L-arginine administration is benefi-
cial in conditions such as trauma, stress, burn or injury, it improves
immune functions and facilitates wound healing [40].
Arginase plays a crucial role in wound healing, a process
severely impaired in the elderly. During wound healing, NOS and
arginase are induced in a time-coordinated manner [41], with
NOS expression peaking first and to be particularly important in
initiating the inflammatory phase. Arginase is expressed later and
is of prime importance in actual wound healing; the conversion of
Figure 5. Classically activated macrophages are not affected by ageing. BMMW were derived from young (6–8 weeks) and older (12 months)
BALB/c mice and stimulated into CAMW with IFN-c and TNF-a or into AAMW with IL-4 or IL-13. (a) Activation markers were determined by flow
cytometry; (b) NO production was assessed by using the Griess reagents. The error bars represent standard deviation and data show the results of
one representative experiment out of four independent experiments.
doi:10.1371/journal.pntd.0000235.g005
Table 3. NO2 production by activated macrophages.
Age groups +L. major 2L. major
3–4 weeks 70.963.3 65.661.2
10 weeks 67.666.1 62.560.3
40 weeks 71.860.1 67.560.5
BMMW were derived from pre-pubertal (3–4 weeks), young adult (10 weeks)
and older (40 weeks) BALB/c mice and differentiated into CAMW with IFN-c and
TNF-a and NO2 production was assessed by using the Griess reagents.
Data show the results of one representative experiment out of two
independent experiments.
doi:10.1371/journal.pntd.0000235.t003
Arginase and Leishmaniasis
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polyamines initiates the repair phase of the inflammatory response
[42]. The reduced expression of arginase in macrophages from
older individuals is likely to result in lower levels of ornithine,
thereby reducing collagen formation and the proliferation of cells,
which might then result in delayed or ineffective wound healing.
In experimental leishmaniasis, uncontrolled disease develop-
ment is generally associated with a strong Th2-type response [11],
however, strong polarized Th2 responses are not sufficient to
Figure 6. Arginase expression is increased in alternatively activated macrophages from young mice. BMMW were derived from young
(6–8 weeks) and older (12 months) BALB/c mice and differentiated into AAMW with IL-4 or IL-13. (a) Activation markers were determined in L. major
infected and uninfected cells by flow cytometry; (b) arginase activity was measured by enzymatic assay. The error bars represent standard deviation
and data show the results of one representative experiment out of four independent experiments.
doi:10.1371/journal.pntd.0000235.g006
Table 4. Arginase activity in activated macrophages.
Age groups +L. major 2L. major
3–4 weeks 266.7623.6 243.1633.3
10 weeks 232.7623.8 221.1650.3
40 weeks 155.6621.3 135.2623.8
BMMW were derived from pre-pubertal (3–4 weeks), adult (10 weeks) and older
(40 weeks) BALB/c mice and differentiated into AAMW with 20 U/ml IL-4 and
arginase activity was measured by enzymatic assay.
Data show the results of one representative experiment out of two
independent experiments.
doi:10.1371/journal.pntd.0000235.t004
Figure 7. Alternatively activated macrophages from young
mice have an increased capacity to promote parasite growth.
BMMW were derived from young (6–8 weeks) and older (12 months)
BALB/c mice, differentiated into CAMW with IFN-c and TNF-a or into
AAMW with IL-4 and infected with L. major. Four days later, the number
of viable parasite per 1610
6 MW was determined by LDA.
doi:10.1371/journal.pntd.0000235.g007
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studies, our results show that amelioration of disease in older mice
does not depend on a switch from a Th2- to a Th1-type response.
The analysis of the Th1-Th2 cytokine balance during ageing has
often resulted in contradictions; both impaired [43] and enhanced
Th2 responses [44] have been reported. Factors such as the use of
different strains of mice and parasites are likely to contribute to
contradictory results.
In support of the increased incidence of leishmaniasis in
children and young adults two studies, using mathematical models,
have shown an association between age and rate of Leishmania
infection and suggest that susceptibility to disease declines with age
[45,46]. However, the relationship between age and susceptibility
to disease remains an open question. The development and
manifestation of disease is the result of a dynamic interplay of a
range of different environmental, host-, vector- and parasite-
derived factors. Many factors such as nutrition, co-infections,
behaviour, differences in metabolic pathways, and prolonged
exposure to repeated bites by infected sandflies are important, but
difficult to measure in patients. It still remains unclear why there
are fewer clinical cases in older people; acquired immunity to re-
infection is likely to be on of the main factors; indeed, unexposed
adults display a higher susceptibility to infection as compared to
the population living in endemic areas [47]. Furthermore,
asymptomatic infections appear to provide natural immunisation
[48]. In another study where VL was shown to be a disease of
children, it was shown that there was a significantly higher
prevalence of adults with positive Leishmanin Skin Test (LST),
suggesting that they had acquired immunity [49] However,
children remain the main risk group for VL [46] and in several
outbreaks, children were the population most at risk
[49,50,51,52,53] suggesting that acquired immunity alone might
not be sufficient to explain age related higher prevalence of
leishmaniasis. The higher level of protection against leishmaniasis
with age could also be due to qualitative differences in cell-
mediated immune responses in children and older people.
Based on our results, we propose that increased arginase
expression and L-arginine catabolism contribute to exacerbation
of leishmaniasis in younger individuals. The therapeutic regulation
of L-arginine metabolism may provide a target for disease
intervention.
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